Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, DIS, SCZ

JAMA Internal Medicine: First International Real-world Data Analysis of Kidney Transplants Supports Redesigned System That Could Benefit Wait-listed Patients in U.S.


PARIS, Aug. 26, 2019 /PRNewswire/ -- Nearly 5,000 people in the US and 3,500 people in Europe die each year while waiting for a kidney transplant. Yet in the US, over 3,500 donated kidneys are discarded annually. Today, the Journal of the American Medical Association (JAMA) Internal Medicine published the data obtained by an international team of kidney transplant specialists comparing the use of donated kidneys in the US to France from 2004-2014, using a new approach based on validated analytic methods and computer simulation. The results revealed that French transplant centers are far more likely to transplant donated kidneys from older kidney donors compared to their US counterparts.

Paris Transplant Group Kidney, Heart and Lung Logo

"These findings are striking and could transform US transplantation practice, leading to thousands of American patients with kidney failure reaping major health benefits," said Dr Peter Reese, Associate Professor of Medicine and Epidemiology at the University of Pennsylvania. "This study is the first to use real-world data analysis supported by computer-based simulated algorithms to tackle this question of how different countries make use of donated kidneys."

"This international comparison of organ acceptance patterns reveals a major lost opportunity for the US to make use of many more viable kidneys from organ donors who are older or have comorbidities," said Pr. Alexandre Loupy, nephrologist at the Department of Nephrology and Kidney Transplantation at Necker Hospital in Paris and Head of the Paris Transplant Group. "In the context of the recent executive order announced by the White House regarding kidney transplantation practices, we are confident that these results will encourage valuable debate and needed changes to the U.S. system."

This analysis builds on the long-standing tradition of utilizing international comparisons to identify best practices for treating patients with chronic conditions. The results show that the approach to kidney allocation and organ use in France would be highly efficient if applied in the US:

"This redesigned allocation system would bring huge benefits for the patients - longer lives, better living conditions," said Dr Olivier Aubert, Assistant Professor at the Paris translational Research Center for Organ Transplantation, INSERM, France. "As most of the waitlisted kidney transplant candidates are on costly dialysis, it would also allow the US healthcare system to achieve enormous savings in the near future."

The lack of organs for kidney transplantation is a major public health problem across the world, due to its attributable mortality and excess cost to healthcare systems while waitlisted patients are maintained on chronic dialysis. It is a major concern for many, including patients, professional societies, organ procurement organizations, the federal government and payers.

About the Paris Transplant Group

The Paris Transplant Group is an active network of highly recognized medical doctors and professors from the major Paris Hospitals, specialized in all aspects of organ transplantation. Its global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field of transplantation by filling the gap between basic science and applied biomedical researches. It is developing a personalized approach of transplant medicine that will integrate multidimensional information deriving from classical histology and biology, clinical science together with novel information coming from ground breaking technologies in immunology, molecular biology, genetics and biomarkers.

More information on www.paristransplantgroup.org.

Contact ? Press relations
Sylvie Delassus  
Syl.delassus@gmail.com

 

SOURCE Paris Transplant Group


These press releases may also interest you

at 06:20
United Cannabis Corporation (the "Company" or "United Cannabis") announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for its application for a new patent that claims methods of...

at 06:05
Axonics Modulation Technologies, Inc. , ("Axonics"), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation ("SNM") devices for the treatment of bladder and bowel dysfunction,...

at 06:05
Health design and innovation studio GoInvo announced today that Meghana Karande, MD will join as Medical Director for the firm. Dr. Karande, a classically trained clinician via Yale and Mount Sinai, will bring her medical expertise to GoInvo's...

at 06:00
Exact Sciences Corp. today announced new outcomes data from two large population-based studies1,2 presented at the 2019 San Antonio Breast Cancer Symposium (SABCS®). The real-world evidence suggests that use of the Oncotype DX Breast Recurrence...

at 06:00
Menopause and the years preceding it have a significant impact on the health and well-being of a majority of women, but more than one-third never discuss their concerns with their health care provider (HCP), and even fewer discuss the issues that...

at 06:00
The Lung Cancer Registry has launched new surveys to do an even better job of capturing important moments in a patient's lung cancer journey. These new surveys include questions about how symptoms and side effect impact quality of life?now and over...



News published on 26 august 2019 at 11:15 and distributed by: